Our Mission

To reduce cancer burden through innovative, epidemiologic research.

Research Projects

The ComPARe Project

Dr. Brenner and Dr. Friedenreich

This project is quantifying the number and proportion of incident cancer cases in Canada, now and to 2042, that could be prevented through changes in modifiable lifestyle and environmental exposures associated with cancer. The broad risk factor categories of interest are: tobacco exposure, dietary factors, physical activity, obesity, environmental factors, infectious diseases and hormonal therapies…

The CHALLENGE Trial

Dr. Friedenreich

The Colon Health and Life Long Exercise Trial (CHALLENGE Trial) is a multi-centre randomized controlled exercise intervention trial that is funded and coordinated by the Cancer Clinical Trials Group at Queen’s University, Kingston. Dr. Friedenreich is a co-investigator on this first ever trial that is enrolling and randomizing 962 Stage II and III colon cancer…

The Breast Cancer and Exercise Trial in Alberta (BETA Trial)

Dr. Friedenreich

The Breast Cancer and Exercise Trial in Alberta (BETA) is a randomized controlled exercise intervention trial. Dr. Friedenreich and her colleagues recruited 400 postmenopausal women aged 50-74 years of age to examine how a one-year high volume (300 minutes per week) versus moderate volume (150 minutes per week) aerobic exercise intervention influences and modifies biomarkers for breast cancer risk …

The Department of Cancer Epidemiology and Prevention Research

Since 2001, the scientists of CEPR have been combining traditional epidemiologic study designs with a molecular epidemiologic emphasis. The collection of demographic, lifestyle, and clinical information has now been expanded to include genetic, cellular, biomarker and metabolomic information from collected biological specimens.

Latest News

Dr. Karen Kopciuk, and colleagues, are recent recipients of a Strategic Clinical Network seed grant

CEPR’s Dr. Karen Kopciuk, together with Dr Huiming Yang and their colleagues, were recently awarded a Strategic Clinical Network (SCN) seed grant entitled:  Test of cure: Use of Human Papillomavirus (HPV) testing to optimize the cervical cancer screening clinical pathway post-treatment.  This grant was one of four grants recently awarded by the SCN for which there was…

Read more

Events

There are no upcoming events.

Follow Us On Twitter

Do You Have Questions?

Send us an email and we will be in touch with you shorty. If you’d like your email directed to one of our Research Scientists, please address the message to them and it will be forwarded.